181 related articles for article (PubMed ID: 36327996)
1. Update on Novel Blood-Based Biomarkers for Lupus Nephritis Beyond Diagnostic Approaches.
Maravillas-Montero JL; Reyes-Huerta RF
Rev Invest Clin; 2022; 74(5):227-231. PubMed ID: 36327996
[TBL] [Abstract][Full Text] [Related]
2. Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis.
Qin S; Wang X; Wang J; Wu H
Lupus; 2024 Feb; 33(2):111-120. PubMed ID: 38227433
[No Abstract] [Full Text] [Related]
3. Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.
Morell M; Pérez-Cózar F; Marañón C
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281193
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S
Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043
[TBL] [Abstract][Full Text] [Related]
5. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
6. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
7. Lupus Nephritis Biomarkers: A Critical Review.
Alduraibi FK; Tsokos GC
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255879
[TBL] [Abstract][Full Text] [Related]
8. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
10. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
Front Immunol; 2020; 11():256. PubMed ID: 32265898
[TBL] [Abstract][Full Text] [Related]
11. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis.
Nicolaou O; Sokratous K; Makowska Z; Morell M; De Groof A; Montigny P; Hadjisavvas A; Michailidou K; Oulas A; Spyrou GM; Demetriou C; Alarcón-Riquelme ME; Psarellis S; Kousios A; Lauwerys B; Kyriacou K
Arthritis Res Ther; 2020 Jun; 22(1):147. PubMed ID: 32552896
[TBL] [Abstract][Full Text] [Related]
13. Novel Biomarkers for Lupus Nephritis in the "OMICS" Era.
Dias R; Hasparyk UG; Lopes MP; de Barros JLVM; Simões E Silva AC
Curr Med Chem; 2021; 28(29):6011-6044. PubMed ID: 33583367
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis.
Anania VG; Yu K; Pingitore F; Li Q; Rose CM; Liu P; Sandoval W; Herman AE; Lill JR; Mathews WR
J Proteome Res; 2019 Mar; 18(3):1264-1277. PubMed ID: 30525646
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
16. Urinary tissue factor (uTF), tissue factor pathway inhibitor (TFPI) and plasmin as novel biomarkers in early diagnosis of lupus nephritis.
Mustafa MH; Tony EAE; Elgendi SS; Abdelkader AS; Salah AA; Madkour RA
Egypt J Immunol; 2024 Jan; 31(1):143-154. PubMed ID: 38224471
[TBL] [Abstract][Full Text] [Related]
17. [Lupus nephritis: from diagnosis to treatment].
Weinmann-Menke J
Inn Med (Heidelb); 2023 Mar; 64(3):225-233. PubMed ID: 36763102
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.
Mahajan A; Amelio J; Gairy K; Kaur G; Levy RA; Roth D; Bass D
Lupus; 2020 Aug; 29(9):1011-1020. PubMed ID: 32571142
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis.
Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Ali MA; Kamal NM; Zidan HE
J Gene Med; 2021 May; 23(5):e3326. PubMed ID: 33617143
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews.
Guimarães JAR; Furtado SDC; Lucas ACDS; Mori B; Barcellos JFM
PLoS One; 2022; 17(10):e0275016. PubMed ID: 36215243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
